Now in Canada: The Only Robotic Prostate Biopsy System with FDA & CE Approval

Engineered for consistency and built to last, our robotic platform delivers dependable performance in demanding clinical environments — ensuring uptime, efficiency, and confidence in every procedure.

Our system is designed with the clinician in mind — featuring ergonomic controls, simplified user interfaces, and responsive feedback that enable precise targeting and seamless navigation throughout procedures. This allows for a smoother surgical workflow and reduced operator fatigue, even in complex cases.

Unlike traditional transrectal biopsies, Mona Lisa uses a transperineal approach that completely avoids rectal contact — eliminating the primary source of biopsy-related infections. This virtually zero infection rate dramatically reduces complications, antibiotic use, and costly hospital readmissions, making it the new standard in safe prostate diagnostics.

The iSR’obot™ Mona Lisa is designed to fit effortlessly into your clinic or hospital's existing infrastructure. With a compact, ergonomic design and compatibility with standard imaging and biopsy workflows, setup is fast and straightforward. This means minimal training time, reduced OR disruption, and increased patient throughput — without compromising quality or accuracy.

With Biobot’s patented dual-cone entry system, Mona Lisa creates a virtual pivot point that allows multiple samples to be taken through a single channel. This approach minimizes tissue trauma, shortens procedure time, and provides complete access to all prostate zones — even hard-to-reach anterior and apex regions.

Every biopsy core taken by the Mona Lisa system is mapped and recorded using digital coordinates. This enables precise repeat sampling during active surveillance, providing confidence in longitudinal tracking, accurate comparisons, and continuity of care over time — all while minimizing unnecessary sampling.

The iSR’obot™ Mona Lisa fuses MRI and ultrasound images with a single click, creating a dynamic 3D model of the prostate. This allows clinicians to visualize and target suspicious regions in real time, improving sampling accuracy and reducing the likelihood of missed clinically significant cancers.

The iSR’obot™ Mona Lisa is designed with scalability in mind. Its modular architecture and precision-guided interface position it for future upgrades — including integration with next-generation imaging, expanded procedural indications, and adjunct therapies such as focal ablation. It’s not just a device; it’s a long-term platform for advancing prostate care.

Mona Lisa accounts for real-world variables like prostate tissue resistance and slight patient movements during the procedure. The system automatically adjusts needle trajectory and depth with sub-millimeter precision, maintaining targeting accuracy and minimizing variability throughout the biopsy.

Clinicians can mix and match from multiple biopsy strategies to create a fully customized plan for each patient. The interface allows easy repositioning or removal of target points, giving urologists complete control over core locations while maintaining robotic consistency in execution.

Mona Lisa automatically generates comprehensive biopsy reports that include annotated 3D prostate models and exact core sampling data. These visual, data-rich reports enhance diagnostic clarity, improve communication with patients, and simplify documentation for follow-up care or multidisciplinary team reviews.

With precise coordinate mapping and consistent core sampling, Mona Lisa supports modern active surveillance strategies. Its reproducibility enables urologists to monitor lesion progression with confidence and tailor intervention timing to each patient’s needs, reducing overtreatment and improving quality of life.

As a Health Canada–approved platform distributed exclusively by PrecisionPro BioTech, Mona Lisa is fully aligned with Canadian clinical standards. We provide local training, support, and consumables — ensuring a smooth deployment and long-term reliability for hospitals and urology clinics across the country.

The iSR’obot™ Mona Lisa is built with user-centric design in mind. From its compact, mobile-friendly structure to an intuitive control console, every aspect of the system is optimized for comfort, workflow efficiency, and ease of use during repetitive procedures — reducing physical strain and streamlining operations.

Thanks to its minimally invasive, targeted approach, many Mona Lisa biopsies can be performed under local or light sedation — avoiding the risks and recovery time associated with general anesthesia. This expands patient eligibility and lowers overall procedural cost and resource use.

With an intuitive interface and streamlined training modules, urologists can quickly gain proficiency using Mona Lisa. PrecisionPro MedTech supports this transition with on-site clinical training and ongoing guidance to ensure immediate confidence and consistent outcomes.

By automating needle positioning and depth, Mona Lisa reduces operator variability, ensuring consistent biopsy results across users and institutions. This standardization enhances diagnostic reliability and builds institutional trust in outcomes — especially in teaching or multi-clinician environments.

Thanks to precise targeting via MRI-ultrasound fusion, Mona Lisa often achieves diagnostic confidence with fewer biopsy cores — reducing trauma, discomfort, and pathology workload without compromising cancer detection rates.

Mona Lisa’s robotic guidance enables confident targeting of traditionally difficult zones such as the anterior, apical, and peripheral regions of the prostate. This improves diagnostic coverage, particularly for patients with prior negative biopsies or atypical lesion locations.

Mona Lisa utilizes a specially designed sheath and stabilizing mechanism for the ultrasound probe. This ensures consistent prostate positioning and image clarity throughout the procedure — minimizing deformation and enhancing the accuracy of real-time fusion imaging.

With robotic guidance and fine-tuned needle control, Mona Lisa achieves targeting accuracy with 1mm. This level of precision is critical for targeting small or deep lesions and avoiding vital structures, especially in challenging anatomical presentations.

Using real-time image fusion and lesion localization, the iSR’obot™ Mona Lisa dynamically adjusts biopsy paths to ensure precise targeting and avoid redundant sampling. This guided trajectory planning enhances procedural accuracy, reduces tissue trauma, and improves efficiency—especially during complex or repeat biopsies.